These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 4374654

  • 21. [Effect of vitamin D metabolites on mineralization of bone tissue and phosphocalcium metabolism disorders in the course of vitamin D deficiency osteomalacia].
    Bordier P, Miravet L, Marie P, Guéris J, Rousselet F, Norman A, Rasmussen H, Ryckewaert A.
    Rev Rhum Mal Osteoartic; 1978 Apr; 45(4):241-8. PubMed ID: 353964
    [No Abstract] [Full Text] [Related]

  • 22. Short-term effects of vitamin D3 and 1,25-dihydroxyvitamin D3 on osteomalacia in uremic rats fed a low calcium-low-phosphorus diet.
    Weisbrode SE.
    Am J Pathol; 1981 Jul; 104(1):35-40. PubMed ID: 6266257
    [Abstract] [Full Text] [Related]

  • 23. Vitamin D compounds and renal osteodystrophy.
    Felsenfeld AJ, Llach F.
    Int J Artif Organs; 1983 Nov; 6(6):281-4. PubMed ID: 6689416
    [No Abstract] [Full Text] [Related]

  • 24. Model for skeletal resistance to vitamin D in renal failure.
    Weisbrode SE, Capen CC.
    Fed Proc; 1976 Apr; 35(5):1225-31. PubMed ID: 177317
    [Abstract] [Full Text] [Related]

  • 25. Renal osteodystrophy in course of periodic dialysis for chronic uremia.
    Kim D, Bell NH, Bundesen W, Putong P, Simon NM, Walker C, Del Greco F.
    Trans Am Soc Artif Intern Organs; 1968 Apr; 14():367-71. PubMed ID: 5701557
    [No Abstract] [Full Text] [Related]

  • 26. Arrest of hyperparathyroid bone disease by the use of dihydrotachysterol in patients undergoing chronic hemodialysis.
    Kaye M, Chatterjee G, Cohen GF, Borra S, Sagar S.
    Trans Assoc Am Physicians; 1970 Apr; 83():245-53. PubMed ID: 5505392
    [No Abstract] [Full Text] [Related]

  • 27. Proceedings: Dihydrotachysterol in the treatment of bone abnormality in patients with renal failure undergoing chronic hemodialysis.
    Suda A, Ota K, Shirasu H.
    Calcif Tissue Res; 1974 Apr; 15(2):159-60. PubMed ID: 4844399
    [No Abstract] [Full Text] [Related]

  • 28. [Evolving aspects of uremic osteodystrophy in the dialized patient].
    Zucchelli P, Fusaroli M, Fabbri L, Catizone L, Pavlica P, Viglietta G, Casanova S.
    J Urol Nephrol (Paris); 1976 Apr; 82(4-5):325-8. PubMed ID: 940176
    [No Abstract] [Full Text] [Related]

  • 29. Calcium and phosphorus metabolism in chronic uremia.
    Fiaschi E, Mioni G, Maschio G, D'Angelo A, Ossi E.
    Nephron; 1975 Apr; 14(2):163-80. PubMed ID: 1093055
    [Abstract] [Full Text] [Related]

  • 30. Bone disease and chronic renal failure.
    Bourke E.
    Ir J Med Sci; 1974 Jul; 0(0):suppl:72-4. PubMed ID: 4604173
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. 'One-alpha'.
    Lancet; 1978 May 06; 1(8071):973-4. PubMed ID: 76898
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Management of metabolic bone disease.
    Br Med J; 1969 Mar 08; 1(5644):621-3. PubMed ID: 5766131
    [No Abstract] [Full Text] [Related]

  • 35. The role of vitamin D in renal bone disease.
    Stanbury SW.
    Clin Endocrinol (Oxf); 1977 Dec 08; 7 Suppl():25s-30s. PubMed ID: 342146
    [No Abstract] [Full Text] [Related]

  • 36. [Studies on the therapy of uremic osteopathy].
    Schaefer K, Schaefer P, Koeppe P, Opitz A, Höffler D.
    Dtsch Med Wochenschr; 1969 Jan 08; 94(2):70-2. PubMed ID: 5782692
    [No Abstract] [Full Text] [Related]

  • 37. The effects of calciferol and its metabolites on patients with chronic renal failure. I. Calciferol, dihydrotachysterol, and calcifediol.
    Voigts AL, Felsenfeld AJ, Llach F.
    Arch Intern Med; 1983 May 08; 143(5):960-3. PubMed ID: 6089682
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Regression of skeletal manifestations of hyperparathyroidism with oral vitamin D.
    Arabi A, Khoury N, Zahed L, Birbari A, El-Hajj Fuleihan G.
    J Clin Endocrinol Metab; 2006 Jul 08; 91(7):2480-3. PubMed ID: 16608887
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.